Starts in:

In-person Professional Development Courses

All times listed are in MOUNTAIN STANDARD TIME

November 1-3, 2024
JW Marriott Phoenix Desert Ridge, Phoenix, Arizona

Basic Level CoursesFor those new to the profession or would like training in a particular topic.

Intermediate Level CoursesFor those with basic knowledge or would like to learn more.

Advanced Level CoursesFor those with experience or looking for a challenging course.

Friday, November 1, 2024, 8:00 AM – 5:00 PM

1. BSL-3 Operations and Management

This course will review the important aspects of BSL-3 Operations and Management from two points of view; “hardware” (i.e., facilities & equipment issues) and “software” (i.e., administrative controls). It will cover various aspects you need to consider in order to operate a BSL-3 facility, such as training, maintenance support, occupational health, waste management, maintenance, performance verification, and emergency response. The instructors will encourage interaction and the exchange of experiences among the attendees. Regulatory aspects from any specific country, or planning, design, or construction-related issues will not be covered.

Objectives:

  • Describe the elements of BSL-3 Operations and Management (risk management, primary barriers, annual performance verification, emergency response, etc)
  • Recognize institutional, management, and user responsibilities
  • Summarize approaches to developing manuals, SOPs, and training

Suggested Background: Basic Risk Assessment and familiarity with BSL-3 Concepts
Target Audience: Safety Professionals, BSL-3 Managers, Containment Engineers, Lab and Scientific Directors

Audience Level: Basic

COURSE FACULTY

J. Paul Jennette, MS, PE, RBP(ABSA), CBSP(ABSA), Cornell College of Veterinary Medicine, Ithaca, NYJ. Paul Jennette, MS, PE, RBP(ABSA), CBSP(ABSA)
Biosafety Engineer
Director of Biocontainment Operations
Cornell College of Veterinary Medicine
Ithaca, NY

Paul Jennette holds Bachelor’s and Master’s Degrees in Environmental Engineering from Cornell and the University of Massachusetts, respectively, and is both a Registered Professional Engineer and a Certified Biological Safety Professional. Since 1999, he has held the position of Biosafety Engineer at the Cornell College of Veterinary Medicine and has also been the Director of Biocontainment Operations there since 2013. Paul’s responsibilities include: design, verification, operation, decontamination, and program management related to Cornell’s BSL-3, ACL-3, and ABSL-3 facilities, which include both research & diagnostic laboratories as well as a BSL-3 large animal necropsy; training all Cornell BSL-3 scientific and support staff and providing direct, in-containment support for BSL-3 diagnostic operations; directing the operations of Cornell’s medical and pathological waste treatment facility, which includes a 5,000-lb/batch carcass digester; serving on Cornell’s Institutional Biosafety Committee and directing the Cornell Vet College Rabies Risk Management Program. Paul serves on biosecurity teams for Select Agent Labs at the Cornell Vet College and provides technical support for the College’s effluent decontamination systems. He served as the American Biological Safety Association’s representative on the ANSI committee to develop a national standard for the verification of BSL-3 facility performance, is a reviewer and lead author of a technical column for the Applied Biosafety journal, and is a member of ABSA’s Professional Development Team. He is a former co-chair of ABSA’s Principles & Practices of Biosafety class as well as a regular instructor for BSL-3 courses offered by the Eagleson Institute and ABSA. In addition to his position at Cornell, Paul provides biocontainment operations consulting services to a variety of academic, governmental, and pharmaceutical clients.

Carrie A. Smith, PhD, RBP(ABSA), CBSP(ABSA), Merrick & Company, Greenwood Village, COCarrie A. Smith, PhD, RBP(ABSA), CBSP(ABSA)
Merrick & Company
Greenwood Village, CO

Carrie Smith has served as a biosafety professional for over fourteen years in academia, the government, and the private sector. In her current role, she serves as a Senior Scientist with Merrick & Company, specializing in biosafety and laboratory operations planning for new laboratories, renovations, and laboratory transitions. Prior to her role at Merrick, she served as BSO and ARO at Oklahoma State University, a biosafety specialist and trainer at University of Wisconsin—Madison, and BSO and ARO at the USGS National Wildlife Health Center. Carrie earned her undergraduate degree in Biology with a concentration in Biotechnology from the University of Delaware and her PhD in Genetics from North Carolina State University. Her research included work with recombinant bacteria, viruses, fungi, and plants as well as biological toxins. As a biosafety professional, Carrie has managed both small and large biosafety programs and her expertise includes BSL-3/ABSL-3 oversight, atypical animals in biocontainment, select agent program management, recombinant technology, plant biosafety, diagnostic labs, and on-line and in-person training development. She serves as Co-Chair and Instructor for ABSA’s Principles & Practices of Biosafety Course and is a member of the Preconference Course Committee.

Dee Zimmerman, Biosafety Consultant, Galveston, TX, ABSA Past President 2019
Dee Zimmerman
Biosafety Consultant
ABSA Past President-2019
Galveston, TX

Dee Zimmerman retired from the University of Texas Medical Branch, Environmental Health and Safety. She was the university biosafety officer, director of the health, safety and training core for the University of Texas Medical Branch—Galveston (UTMB) National Laboratory, senior environmental health and safety consultant in the Biological Safety program and served as the university’s select agent program alternate responsible official, IBC member and coordinator. Her duties include working closely with research staff in BSL-2, BSL-3, BSL-4, ABSL-2, 3, and 4 laboratories working closely with research scientists, biocontainment engineers, facility staff and occupational health. Dee was with the University of Texas Medical Branch from 1982 until retiring in 2017. She attended Inter-American University in Puerto Rico and was the lab and safety coordinator for the Marine Ecology Division, Center for Energy and Environmental Research at the University of Puerto Rico. Dee is the 2019 Past President of ABSA International.

CONTACT HOURS

This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.

Friday, November 1, 2024, 8:00 AM – 5:00 PM

2. IATA Infectious Substance Shipping Certification

This course is appropriate for those who have some experience with infectious substance handling or shipping but may not have been certified within the past 3 years and those with little to no previous training. The course utilizes several facilitated learning activities. There will be group discussions and interactive exercises focused on the essential areas of infectious substance shipping. New IATA requirements for competency assessment will be administered short interactive assignments, and an online exam. Participants will mark, label, package, and complete documentation for infectious substance shipments (Category A, Category B, and Exempt Patient Specimens), and review applicable regulations with a focus on IATA. Additional U.S. DOT differences will also be addressed. This course is appropriate for those responsible for packaging, marking, and labeling shipments of all categories of infectious substances, dry ice, and liquid nitrogen. Participants have both an online exam (score at least 80%) and practical exercises to complete to demonstrate competency. Successful completion of the course will qualify attendees for IATA/DOT certification.

Objectives:

  • Review and restate shipping regulations for both air and ground with a particular focus on 49 CFR US DOT and IATA air regulations
  • Conduct a risk assessment and be able to properly classify and identify infectious substances for transport purposes
  • Package, mark, label, and prepare documentation for shipments of infectious substances to meet regulatory requirements for air and ground shipments

Suggested Background: None
Target Audience: All Safety Professionals, New Biosafety Professionals, Laboratory Workers

Audience Level: Basic

COURSE FACULTY

Eric Cook, MPH, Sandia National Laboratories, Albuquerque, NM
Eric Cook, MPH
Senior Member – Technical Staff
Sandia National Laboratories
Albuquerque, NM

Eric Cook is a Senior Member of the Technical Staff in the International Biological and Chemical Threat Reduction Program at Sandia National Laboratories where his work focuses on promoting global laboratory biorisk management. He serves as one of the program’s lead trainers. Eric served as the Biosafety Officer for Dartmouth College in Hanover, NH for five years where he managed the Biosafety Program and Institutional Biosafety Committee. Prior to working at Dartmouth, Eric was an Assistant Biosafety Officer at the Massachusetts Institute of Technology for six years. While at MIT, Eric completed his Master’s Degree in Public Health at Boston University with a focus on Environmental Health. Eric has a B.S.in Molecular Biology from Brigham Young University where he worked in a recombinant DNA lab for two years assisting with work in phylogenetics. He is certified by the National Registry of Certified Microbiologists as a Specialist Microbiologist in Biological Safety Microbiology and previously by ABSA International as a Certified Biological Safety Professional. Eric has particular expertise in dangerous goods and infectious substance shipping. He worked for three years at Saf-T-Pak, Inc. developing training programs and packaging for shipping infectious substances.

CONTACT HOURS

This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.

Friday, November 1, 2024, 8:00 AM – 5:00 PM

3. Basic Risk Assessment

Rapid scientific and technological advances continue to challenge the biosafety community in determining and establishing the practices and containment necessary to avoid exposure to hazardous biological agents and materials found in the laboratory. This introductory course will provide an opportunity to incorporate the basic knowledge and skills necessary to perform risk assessments for working safely with pathogens (human and animal) and rDNA (genetically modified organisms or viral vectors). Using case studies, attendees will work together to conduct risk assessments by determining the hazards involved; the appropriate questions to ask to address the potential risks associated with the intended activities and make recommendations on appropriate containment and practices required to work safely. Each group will present their conclusions from the activity.

Objectives:

  • Identify and list determinants for assessing risk (host, environment, agent)
  • Complete the steps of a risk assessment and determine steps to manage risk (mitigation)
  • Identify resources and references for risk assessment/management

Suggested Background: None
Target Audience: New Biosafety Professionals, Laboratory Workers

Audience Level: Basic

COURSE FACULTY
CONTACT HOURS

David Harbourt, PhD, RBP(ABSA), CBSP(ABSA), SM(NRCM)David Harbourt, PhD, RBP(ABSA), CBSP(ABSA), SM(NRCM)
Safety and Occupational Health Manager
Office of Management, Center for Veterinary Medicine
U.S. Food and Drug Administration

Dr. David Harbourt is a Safety and Occupational Health Manager for the Center of Veterinary Medicine at the U.S. Food and Drug Administration (FDA). Prior to his current position, he served as the Program Director of the National Biosafety and Biocontainment Training Program (NBBTP) at the National Institutes of Health. Before that, he served in a variety of roles at the United States Army Medical Research Institute of Infectious Diseases (USAMRIID) including Biosafety Officer, Chief of the Biosafety Division and Deputy Director of the USMARIID Transition Office (2012-2021). Prior to working at USAMRIID, he was a fellow in the NBBTP. Preceding the fellowship, he graduated with his B.S. in Biochemistry from Virginia Tech (’05) and his Ph.D. in Toxicology from UNC-Chapel Hill (’09).

Dr. Harbourt has been an active member of ABSA International since 2010; has previously served as the Chair of the Preconference Course Committee and Chair of the Training Tools and Resources Committee; and currently serves as a member of the Exam Development Board for the CBSP Exam. He has also been a member of the Standards Committee, Professional Development Team, and BSAT Community Advocate Committee for ABSA. He has recently been named Co-Chair of the ABSA Ambassadors Committee. Locally within the Chesapeake Area Biosafety Association, Dave has been a Councilor, Chair of the Scientific Program Committee for its annual symposium, and Chair of the Pre-Symposium Committee. Previously, Dr. Harbourt served as Chair of the DoD Biosafety and Scientific Review Panel.

Dr. Harbourt has published several articles on topics relevant to biosafety including bacteriology, virology, agent inactivation, effluent decontamination systems, and risk assessment. He has also taught courses both at ABSA and at local universities on biosafety, risk assessment, emergency management, and effluent decontamination systems. Dave is a Registered Biosafety Professional and Certified Biological Safety Professional through ABSA International and a Specialist Microbiologist (NRCM) through the American Society of Microbiology.

Rachel Gamble, DrPH, RBP(ABSA), CBSP(ABSA), Pond & Company, Peachtree Corners, GARachel Gamble, DrPH, RBP(ABSA), CBSP(ABSA)
Pond & Company
Peachtree Corners, GA

Rachel is the Associate Director of Biorisk Management Programs within the Life Sciences practice at Merrick. She holds a Doctor of Public Health in Occupational and Environmental Health Sciences (concentration in epidemiology and disease control) from The University of Texas School of Public Health. In addition to her degrees, she has held the CBSP credential since 2011, and has over 18 years of experience in the field. Previously, Rachel served as the Director of the Office for Environmental Safety and the high containment/select agent research facility at Baylor College of Medicine (BCM). She was also an assistant professor in the Molecular Virology and Microbiology department. Since her departure from BCM and joining Merrick, she has diversified and grown her knowledge and experience base by working on projects for the USDA, Department of Homeland Security, Public Health Ontario, Centro Medico NAVAL (CEMENAV), NASA, Biosecurity Engagement Programs in the East Asia Pacific Region, MD Anderson Cancer Center, NIH, Labs Canada, and various colleges and universities across the United States.

Katie George, PhD, MPA, RBP(ABSA)Katie George, PhD, MPA, RBP(ABSA)
Associate Partner and Human Gene Therapy Biosafety Officer
Clinical Biosafety Services
Chesterfield, MO

Katie George lives in Missoula, Montana and is currently an Associate Partner and Human Gene Therapy Biosafety Officer for Clinical Biosafety Services (Chesterfield, MO) working with clinics, universities, and hospitals in the United States and Canada prepare for IBC review of Human Gene Therapy (HGT) clinical trials.

Katie holds a BS in Biology from the University of Iowa, a PhD in Biochemistry from Northwestern University, and an MPA from Purdue University. After obtaining her PhD, she was a post-doctoral fellow at the National Institutes of Health researching mycobacterial pathogenesis. After her post-doctoral position, she served as faculty at the University of Montana teaching and leading a research team studying organophosphate pesticide toxicology. Later, she taught medical students at the Medical University of the Americas (Nevis, West Indies). During her career, Katie has worked as a toxicology consultant for the State of Montana Public Defenders and the State of Montana Department of Public Health and Human Services.

Katie has been an ABSA member since 2020 and a Registered Biosafety Professional since 2021. She currently serves on the Distance Learning Committee for ABSA International.

Berenice Arriaga, CBSP(ABSA), SM(NRCM)
University of Texas at El Paso
El Paso, TX

This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.

Friday, November 1, 2024, 8:00 AM – 5:00 PM

4. Intersection Between Biosafety and Infection Control: An Introduction to Infection Control and Biosafety in Clinical Spaces

This course is meant for the biosafety professional who would like to learn more about application of biosafety principles in the clinical environment and partnering with Infection Control Departments in health systems. This is increasingly important as clinical trials using biological therapeutics, such as human gene transfer (HGT), require safety professionals to develop investigational product handling, preparation, and administration protocols that align with current clinical safety practices and environments. The goals of this course are to introduce different clinical environments, specific biosafety considerations for each space, hospital regulatory requirements that influence safety protocols, and how to collaborate with hospital infection control professionals to operationalize safety protocols in a way that’s meaningful to hospital staff.

Objectives:

  • Describe inpatient, procedural and outpatient clinical environments and how this affects implementation of Biosafety Practices
  • Restate the similarities and differences between biosafety levels, isolation precautions and standard precautions
  • Summarize how NIH and BMBL guidelines relate to hospital regulatory and accreditation requirements when creating protocols for HGT clinical trials

Suggested Background: Principles and Practices of Biosafety® (PPB), Risk Assessment
Target Audience: All Safety Professionals, All Biosafety Professionals

Audience Level: Intermediate

COURSE FACULTY

Allison Reeme, PhD, CIC, RBP(ABSA)Allison Reeme, PhD, RBP(ABSA)
Shield Consulting
Chesterfield, MO

Allison Reeme has over 6 years of experience in infection prevention and hospital epidemiology at an academic medical center consisting of acute care, procedural, and outpatient care settings. She has led multiple quality improvement projects, assisted in hospital credentialing preparedness, mitigating outbreaks of multidrug-resistant organisms, and designing clinical spaces. Allison has 6 years of experience serving as a Human Gene Therapy expert (HGT) on the Institutional Biosafety Committee, supported a CAR-T cell manufacturing facility and assisted with the training and education of clinical staff supporting HGT clinical trials. Allison has 5+ years’ experience working in A/BSL-2 and A/BSL-3 laboratories conducting bench research with viral and bacterial pathogens. She is certified through the Certification Board of Infection Control and Epidemiology, is a Registered Biosafety Professional through The American Biological Safety Association and has doctoral degrees in Microbiology, Immunology & Molecular Genetics and Translational Science.

Caitlyn Hauke, PhD, RBP(ABSA), CBSP(ABSA)
Sabai Global – Clinical Biosafety Services
Chesterfield, MO

CONTACT HOURS

This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.

Saturday, November 2, 2024, 8:00 AM – 5:00 PM

5. Facilities Fundamentals for Biosafety Professionals

This course is aimed at strengthening biosafety professionals knowledge of how facility operations support overall biocontainment operations. The first portion of the course will familiarize attendees with the general concepts biosafety-related facility design and their roles in it, along with the fundamentals of HVAC system operation in the context of BSL-2 and BSL-3 facilities. Topics in this portion of the course include: the role of biosafety personnel in biocontainment facility design, renovation, and operations, understanding design drawings and related construction documents, what the relationship is of facility features to biosafety levels, and HVAC components and their function relative to biocontainment. The instructors will lead discussions of more detailed aspects of containment facilities and their operation, including: specific infrastructure, equipment, and systems related to operation of a biocontainment facility; autoclave function, waste management, associated facility infrastructure; room decontamination in relation to facility components; interactions between facilities and containment equipment; security, operations, and biosafety. Through a mixture of presentations from experts in the field and interactive exercises, attendees will reinforce their knowledge of facility system function and their roles in facility design, construction, and operation. The target audience for the course is biosafety professionals who come with backgrounds other than facilities, and it is open to both newcomers and seasoned veterans in the field.

Objectives:

  • Restate the roles of biosafety professionals in facility design and operation
  • Explain practical approaches for reviewing design documents.
  • Describe the function of discrete facility infrastructure, equipment, and systems related to biocontainment facility operations

Suggested Background: BSL-3 Operations and Management, Fundamentals of Biosafety, Principles and Practices of Biosafety® (PPB)

Target Audience: All Biosafety Professionals, All Safety Professionals

Audience Level: Basic

COURSE FACULTY

J. Paul Jennette, MS, PE, RBP(ABSA), CBSP(ABSA), Cornell College of Veterinary Medicine, Ithaca, NYJ. Paul Jennette, MS, PE, RBP(ABSA), CBSP(ABSA)
Biosafety Engineer
Director of Biocontainment Operations
Cornell College of Veterinary Medicine
Ithaca, NY

Paul Jennette holds Bachelor’s and Master’s Degrees in Environmental Engineering from Cornell and the University of Massachusetts, respectively, and is both a Registered Professional Engineer and a Certified Biological Safety Professional. Since 1999, he has held the position of Biosafety Engineer at the Cornell College of Veterinary Medicine and has also been the Director of Biocontainment Operations there since 2013. Paul’s responsibilities include: design, verification, operation, decontamination, and program management related to Cornell’s BSL-3, ACL-3, and ABSL-3 facilities, which include both research & diagnostic laboratories as well as a BSL-3 large animal necropsy; training all Cornell BSL-3 scientific and support staff and providing direct, in-containment support for BSL-3 diagnostic operations; directing the operations of Cornell’s medical and pathological waste treatment facility, which includes a 5,000-lb/batch carcass digester; serving on Cornell’s Institutional Biosafety Committee and directing the Cornell Vet College Rabies Risk Management Program. Paul serves on biosecurity teams for Select Agent Labs at the Cornell Vet College and provides technical support for the College’s effluent decontamination systems. He served as the American Biological Safety Association’s representative on the ANSI committee to develop a national standard for the verification of BSL-3 facility performance, is a reviewer and lead author of a technical column for the Applied Biosafety journal, and is a member of ABSA’s Professional Development Team. He is a former co-chair of ABSA’s Principles & Practices of Biosafety class as well as a regular instructor for BSL-3 courses offered by the Eagleson Institute and ABSA. In addition to his position at Cornell, Paul provides biocontainment operations consulting services to a variety of academic, governmental, and pharmaceutical clients.

Rachel Gamble, DrPH, RBP(ABSA), CBSP(ABSA), Pond & Company, Peachtree Corners, GARachel Gamble, DrPH, RBP(ABSA), CBSP(ABSA)
Pond & Company
Peachtree Corners, GA

Rachel is the Associate Director of Biorisk Management Programs within the Life Sciences practice at Merrick. She holds a Doctor of Public Health in Occupational and Environmental Health Sciences (concentration in epidemiology and disease control) from The University of Texas School of Public Health. In addition to her degrees, she has held the CBSP credential since 2011, and has over 18 years of experience in the field. Previously, Rachel served as the Director of the Office for Environmental Safety and the high containment/select agent research facility at Baylor College of Medicine (BCM). She was also an assistant professor in the Molecular Virology and Microbiology department. Since her departure from BCM and joining Merrick, she has diversified and grown her knowledge and experience base by working on projects for the USDA, Department of Homeland Security, Public Health Ontario, Centro Medico NAVAL (CEMENAV), NASA, Biosecurity Engagement Programs in the East Asia Pacific Region, MD Anderson Cancer Center, NIH, Labs Canada, and various colleges and universities across the United States.

Steve Helgren, AIA, NCARB
Merrick & Company
Greenwood Village, CO

Fahim Manzur, RBP(ABSA)
Merrick & Company
Greenwood Village, CO

CONTACT HOURS

This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.

Saturday, November 2, 2024, 8:00 AM – 5:00 PM

6. Articulating the Value of Your Biosafety Program

A recurrent challenge confronting biosafety professionals is the ability to garner necessary program resources to achieve desired goals and objectives. The basis for this difficulty is that, on a good day in the world of biosafety, “nothing happens”. The underlying challenge is that upper management may not fully appreciate or understand all the effort and resources that went into making “nothing happen”. Biosafety professionals in particular experience difficulty in this regard because many in the profession have received intensive training in the biological sciences, but little or no training in the area of program management. This course focuses on some key management approaches and techniques that can be used within biosafety programs to help improve stakeholder understanding, which in turn can result in the provision of necessary programmatic resources. Numerous real-world examples of successful applications of the techniques presented will be displayed for review and discussion. Ample time will be provided throughout the course for attendee interaction and inquiries.

Objectives:

  • Identify various biosafety programmatic measures and metrics that should be captured and communicated
  • Paraphrase the techniques that can be used for displaying biosafety data in ways that others can readily understand and appreciate it
  • Describe how biosafety programs can assist with other basic safety program needs to help avoid the notion of program duplication of efforts and to improve safety and client satisfaction levels

Suggested Background: None
Target Audience: All Safety Professionals, All Biosafety Professionals

Audience Level: Basic

COURSE FACULTY

Robert Emery, DrPH, RBP(ABSA), CBSP(ABSA), University of Texas-Houston, Houston, TX
Robert Emery, DrPH, chp, cih, csp, chmm, cpp, ARM, RBP(ABSA), CBSP(ABSA)
Vice President of Safety, Health, Environment & Risk Management
University of Texas Health Science Center—Houston
Houston, TX

Robert Emery is Vice President for Safety, Health, Environment & Risk Management for The University of Texas Health Science Center at Houston (UTHealth Houston) and Professor of Occupational Health at the University of Texas School of Public Health. Bob is a board licensed Medical Health Physicist, a Certified Health Physicist (CHP), Certified Industrial Hygienist (CIH), and a Certified Safety Professional (CSP). He holds both ABSA International credentials; the Registered Biosafety Professional (RBP) and Certified Biological Safety Professional (CBSP).

Kristin King, DrPH, CBSP(ABSA), University of Texas-Houston, Houston, TX

Kristin King, DrPH, CPH, CHSP, CIC, CBSP(ABSA)
Biological Safety Manager
University of Texas Health Science Center—Houston
Houston, TX

Kristin King is the Biological Safety Program manager within Environmental Health & Safety at The University of Texas Health Science Center at Houston (UTHealth Houston).

Zackary Becker, MPH, CBSP(ABSA)
UTHealth—Houston
Houston, TX

CONTACT HOURS

This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.

Saturday, November 2, 2024, 8:00 AM – 5:00 PM

7. Engineering for the Biosafety Professional Part I

Biosafety professionals (BSOs) need to be involved and knowledgeable in the operation, maintenance, and certification of their biocontainment facilities and building systems. The BSO is called upon to participate in the planning, design, and validation of a new biocontainment laboratory or renovation of an existing facility. This course provides basic engineering principles that are useful in the planning, design, and operation of a BSL-3 facility and is intended to fill the gap by providing basic knowledge for understanding the processes used in the planning, design, construction, maintenance, and operation of a BSL-3 laboratory. For the BSO to participate in these activities, they need to understand engineering fundamentals, develop skills to ask questions in engineering terms, and possess the confidence to question the answers. This is the first course of a two-part series offered in alternating years. Part I of the course will provide information relevant to BSL-3 facilities for the determination of air change rates, define HVAC containment boundaries, interpret design drawings, understand HEPA filtration, provide an introduction to determining room heat loads and ventilation rates, provide concepts in directional airflow and room pressure differentials as well as an introduction to HVAC components. There will be presentations on planning, design (with a checklist), construction oversight, commissioning, certification/validation/ANSI Z9.14 Standard, maintenance, and operations. Upon course conclusion, the attendees should have the knowledge to better understand engineering issues in the planning, design, construction, commissioning, certification/validation, and post-occupancy of biocontainment facilities, be able to formulate informed questions, be able to interact with maintenance personnel and integrate facility operations with the biosafety program.

Objectives:

  • Discuss engineering principles and the design and construction process of a BSL-3 laboratory
  • Recall the phases and the strategies of a BSL-3 laboratory design
  • Identify potential problems before construction begins
  • Describe the elements of a quality assurance program

Suggested Background: None
Target Audience: All Biosafety Professionals, Operations and Maintenance Staff

Audience Level: Intermediate

COURSE FACULTY

Juan Osorio, IEJuan Osorio, IE
Chief Operating Officer
World BioHazTec Corporation
Pasadena, MD

Juan Osorio provides consulting in engineering with a focus in high and maximum containment laboratories (BSL-3 and BSL-4), biomedical facilities, hospitals and research facilities. In this role, he consults with clients regarding laboratory planning, programming, commissioning, validation and third party certification activities for significant biocontainment, laboratory, vivarium, safety and healthcare projects. Mr. Osorio has consulted, reviewed, validated, and certified biocontainment laboratories, mission critical government institutions, vivaria, and world-class medical facilities. He has vast experience in the high- and maximum containment fields and participates on biocontainment projects in the United States, Asia, and South America. Mr. Osorio contributes to the design, construction, validation, third-party certification, and maintenance of such facilities. He has served frequently as a consultant for the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) for industrial engineering issues in biocontainment, general laboratory, hospital, and vivarium projects. He has assisted in the development of high- and maximum containment government guidelines and regulations for the NIH.

Theodore Traum PE, CCP, DGCP
Theodore Traum PE, CCP, DGCP
Principal Engineer and Board Member
World BioHazTec Corporation
Pasadena, MD

Theodore (Ted) Traum has over thirty years of experience in engineering with a focus in high- and maximum containment laboratories (BSL-3 and BSL-4), biomedical facilities, hospitals and researchfacilities. In this role, he consults with clients and oversees laboratory planning, programming, commissioning, validation, and third-party certification activities for significant biocontainment, laboratory, vivarium, safety and healthcare projects. Following the September 11, 2001 attacks, Mr. Traum received a considerable influx of biosafety and biocontainment projects to combat bioterrorism. Capitalizing on his niche expertise in this fast growing industry and its previous work with the JCAHO statement of conditions, Mr. Traum focused his business development efforts towards developing acertification program for biocontainment laboratories, their design, construction, operation, biosafety consultation, and maintenance through World BioHazTec (WBHT). Being one of the only few firms in the United States with a significant level of expertise and previous success in niche projects for the healthcare and research laboratories, Mr. Traum became sought after nationally and internationally as the premier consultant for oversight, management, and certification of biocontainment facilities. Mr. Traum has consulted, reviewed, validated, and certified biocontainment laboratories, mission critical government institutions, vivaria, and world-class medical facilities. He is a highly respected professional engineer in the high- and maximum containment field and is sought worldwide for his experienceand expertise in design, construction, third-party certification, and maintenance of such facilities. He has served frequently as a consultant for the National Institutes of Health (NIH) and the U.S. Food and Drug Administration for HVAC, mechanical, and industrial engineering issues in biocontainment, general laboratory, hospital, and vivarium projects.

CONTACT HOURS

This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.

Saturday, November 2, 2024, 8:00 AM – 5:00 PM

8. Keeping it Going: Maintaining and Improving a Select Agent Program Over the Long Term

Keeping a select agent program going can be difficult, especially in the face of ever-changing regulatory requirements and limited resources. Established procedures may suddenly become unacceptable, interrupting research and frustrating laboratorians. Likewise, a single unexpected adverse event can put an entire program at risk. Being prepared to deal with such changes and events is critical to maintaining a robust program. Anticipating future challenges can be even more advantageous, elevating a program from good to great. A proactive approach can minimize the impact of new requirements and reduce duration and frequency of crises sparked by sudden, unexpected requirements or events. This course will explore strategies for maintaining and improving an existing program, including how to anticipate and respond to new requirements. The focus will be on U.S. select agent requirements, although a small section on comparable requirements in the international community will be included. Strategies will be based on the instructors’ experience with their program with additional input solicited from class attendees during open discussions. Topics will include select agent program history; effective oversight; efficiently meeting ongoing requirements; reporting, responding to, and analyzing incidents; suitability program case studies; inactivation requirements, including “failure” investigation; and inspection preparation and response. The course will consist of topical presentations followed by group discussions aimed at facilitating application of presented strategies to attendees’ individual programs and providing a platform to capitalize on attendees’ collective experience.

Objectives:

  • Identify strategies for efficiently maintaining a select agent or equivalent program in good standing with ongoing requirements, including anticipating areas of emphasis in future inspections and/or future regulatory changes
  • Indentify strategies for preparing for and responding to regulatory inspections, including strategies to efficiently implement necessary changes
  • Review a series of suitability program case studies and identify strategies for dealing with potential suitability concerns
  • Summarize inactivation requirements and identify successful strategies for compliance

Suggested Background: None
Target Audience: All Safety Professionals, Select Agent Program Safety Professionals

Audience Level: Intermediate

COURSE FACULTY
Amy Vogler, PhD, RBP(ABSA), Northern Arizona University, Flagstaff, AZ

Amy Vogler, PhD, RBP(ABSA)
Associate Director – Pathogen and Microbiome Institute
Northern Arizona University
Flagstaff, AZ

Amy Vogler is an Associate Director at the Pathogen and Microbiome Institute (PMI) at Northern Arizona University (NAU). She has worked at PMI since 1997 as a researcher and has been responsible for managing their BSL-3 Select Agent laboratory since 2009. She received her B.S. in Microbiology and Chemistry in 1999 and her Ph.D. in Biology in 2003 from NAU and is an author on 45 publications in the field of population genetics and molecular epidemiology of bacterial pathogens. She continues to conduct research on Yersinia pestis while also managing the BSL-3 laboratory. She received her RBP in 2012.

Shelley Jones, MS, RBP(ABSA), Northern Arizona University, Flagstaff, AZ

Shelley Jones, MS, RBP(ABSA)
Director of Biological Safety | Responsible Offical
Northern Arizona University
Flagstaff, AZ

Shelley Jones is the Director of Biological Safety and Responsible Official at Northern Arizona University. She received her B.S. from Illinois State University and her M.S. from Arizona State University, both in environmental disciplines. Shelley has over 30 years of diverse experience in environmental health and safety. She has been a Responsible Official/Alternate Responsible Official for 19 years.

CONTACT HOURS

This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.

Saturday, November 2, 2024, 8:00 AM – 5:00 PM

9. Fixing Broken Laboratories

Laboratory construction represents a small segment of the global construction industry, encompassing various types such as food and chemical laboratories. However, facilities that integrate biorisk considerations into their core design are relatively rare. Even scarcer are laboratories where biosafety and biosecurity design are critical for safe operation. The scarcity of such construction projects means that the skills and competencies required to deliver biorisk laboratories are equally uncommon. Typically, very few designers have experience designing even one facility, far less have significant experience designing multiple facilities. Those in the construction field change jobs often, so even companies with good historic experience cannot field the same team delivering successful projects in the past. Similarly, client-side laboratory construction experience may be lacking. New facilities are scarce. Those involved from client and user teams may have limited or no experience of how to interact with construction industry professionals to achieve a fully functional facility, fit for the needs and purpose intended. This lack of competence on one or both sides of a design team can lead to problems which only manifest themselves after a great deal of time and money has been invested, and can result in a range of problems. Such issues can persist and, in some cases, hinder or prevent the effective operation of the facility. This course aims to introduce the fundamentals of designing and constructing biosafety laboratories. Through case studies, the attendees will explore common problems in laboratory design and construction. Each case study will introduce problem solving and fault-finding techniques, including root cause and solutions. Suboptimally functioning laboratories are not uncommon, but with the right approach, most can be remediated. Attendees are expected to gain in confidence and learn structured fault-finding techniques that they can apply to address challenges in their own facility.

Objectives:

  • Summarize the fundamentals of biosafety laboratory design
  • Identify what structured fault-finding techniques are available to evaluate sub-optimal, failing or failed laboratories
  • Apply techniques learned to real life experiential problems with sub-optimal, under-performing, failing or failed facilities

Suggested Background: Biosafety and Biosecurity Training Course (BBTC®), BSL-3 Operations and Management, Fundamentals of Biosafety, Principles and Practices of Biosafety® (PPB)
Target Audience: All Safety Professionals, Experienced Biosafety Professionals, Facility Managers and Laboratory Managers

Audience Level: Advanced

COURSE FACULTY

Mark Wheatley, BEng, CEng, MCIBSE, Environment & Services Ltd., Cornwall, United KingdomMark Wheatley, BEng, CEng, MCIBSE
Environment & Services Ltd.
Cornwall, United Kingdom

Mark Wheatley is a Biocontainment Engineer, Chartered Building Services Engineer and Specialist Consultant in Containment Laboratory Design, Construction, Operation and Maintenance (since 1998). Mark provides consultancy services to companies, organizations, institutions, governments and NGOs worldwide. Marks particular specialism lies in detailed investigation, fault-finding, root cause analysis, and remediation of poorly functioning, failing or failed biocontainment facilities. Mark has 25+ years biocontainment facility related problem-solving experience. Mark is currently project manager for the MORU DTRA BTRP RRLFMDSEA renovation project in Thailand. Mark acted as technical expert in biocontainment engineering advising the Dutch NAC WHO GAPIII audit team (2019-23). Mark was Senior Biocontainment Engineer at Defra UK (2018-19). Mark was Key Expert 4, EU CBRN CoE Project 46 (2015-18) during which he developed and delivered training to Engineers, Architects and Scientists from 8 ASEAN countries on ‘Laboratory Design, Construction, Operation and Management’ including writing the booklet “A broad introduction to the design and construction of biosafety laboratories in low-resource settings”. Mark contributed to the WHO LBM4 monograph on Laboratory Design and Maintenance and has volunteered twice on the SNL twinning programme. Mark is a member of ISO TS 7446 ISO 35001 guidance writing team. Mark specializes in biocontainment facility technical peer-review and is often invited as a technical expert to join structured risk assessment teams reviewing critical systems such as: EDS; Autoclaves; high containment HVAC and Controls. At Defra, Mark worked closely with a specialist functional safety team to satisfy the requirements of UK HSE. Mark first worked on structured risk assessments during the response to HSE investigations after the 2007 UK FMD Outbreak. Mark worked closely with HSE delivering a £3M+ project of improvements to enhance safety systems at the Pirbright and Compton sites of the Institute for Animal Health. Mark lives in Cornwall, UK.

CONTACT HOURS

This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.

Saturday, November 2, 2024, 8:00 AM – 12:00 PM

10. Introduction to Biosafety

This course is designed for individuals new to the profession, EHS professionals needing an understanding of biosafety, and for those interested in a refresher on the fundamental principles and practices of biosafety. Participants will gain a solid foundation in biosafety concepts, enabling them to understand and mitigate risks associated with biological materials in various laboratory settings. Class content and discussion include regulatory standards and guidelines, hazard identification, risk assessment and mitigation. Mitigations discussed will include biosafety levels and facility design, proper choice and use of personal protective equipment, waste management, decontamination and sterilization, and more.

Objectives:

  • Identify the breadth of duties that may be central or peripheral to a biosafety professional
  • Restate the major sources of regulatory and guidance materials available to them
  • Describe the roles others within the institution play in supporting biosafety

Suggested Background: None
Target Audience: New Biosafety Professionals, Laboratory Workers

Audience Level: Basic

COURSE FACULTY

Paul Meechan, PhD, RBP(ABSA), CBSP(ABSA)
Biosafety Consultant
Catonsville, MD

Paul J. Meechan is currently a biosafety consultant, providing guidance and training to a number of academic and government institutions regarding safe containment practices. He has over 30 years’ experience in the field, including positions at the CDC and Merck and Co., Inc. He was also the CDC editor for the 6th edition of the NIH/CDC manual Biosafety in Microbiological and Biomedical Laboratories. Paul has served as President of ABSA International and holds a PhD from the University of Rochester.

Scott Alderman, MS, CBSP(ABSA)
Duke University
Durham, NC

CONTACT HOURS

This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.

Saturday, November 2, 2024, 8:00 AM – 12:00 PM

11. Integrating AI into Synthetic Biology: A Biosecurity Risk Assessment Course

This intensive half-day course is designed for biorisk management professionals who are at the forefront of integrating Artificial Intelligence (AI) into synthetic biology. With AI rapidly transforming scientific research and applications, its adoption presents unique biosecurity challenges. This course provides an in-depth look into the specialized biosecurity risk assessment process tailored for AI applications in synthetic biology, combining theoretical foundations with practical, hands-on exercises and interactive case studies. Some of the topics to be covered include: an overview of AI technologies and their applications in synthetic biology; fundamentals of biosecurity risk assessment for AI; discuss the concepts of vulnerability, threat, risk, consequence, and mitigation; develop a dynamic risk management plan and strategies for continuous monitoring and updating of risk assessments to address the evolving nature of AI technologies and synthetic biology applications. Attendees will also discuss the challenges of maintaining an adaptable and proactive risk management stance in a rapidly advancing scientific field.

Objectives:

  • Explain at a basic level the AI integration in synthetic biology research
  • Identify associated biosecurity risks
  • Apply a structured approach to assess these risks using newly developed tools and methodologies

Suggested Background: Fundamentals of Biosafety
Target Audience: All Safety Professionals, All Biosafety Professionals

Audience Level: Basic

COURSE FACULTY

Leyma De Haro, PhD, RBP(ABSA)
Merrick & Company
Greenwood Village, CO

Dr. Leyma P. De Haro received a BS in Biochemistry from California State University, Los Angeles, and holds a PhD in Biomedical Sciences from the University of New Mexico. She is a Registered Biosafety Professional (RBP) by ABSA International. She completed two postdoctoral fellowships, including one at Los Alamos National Laboratory. Dr. De Haro worked at Sandia National Laboratory, in the internationally renowned Global Chemical and Biological Security Team, where she specialized in Biosafety and Biosecurity on a global scale. She is currently a Senior Scientist specializing in Biosafety and Laboratory Operations at Merrick. Dr. De Haro has over 14 years’ post PhD experience as a scientist, helping laboratories and organizations enhance their biosafety and biosecurity practices. Her background in innovative scientific research enables her to understand the unique safety challenges laboratories and organizations face in today’s rapidly evolving world of life sciences. With a keen focus on fostering a culture of responsibility and safety, Dr. De Haro is committed to promoting best practices in biosafety and biosecurity worldwide, supporting the life sciences community in pursuing groundbreaking discoveries and innovations.

CONTACT HOURS

This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.

Saturday, November 2, 2024, 1:00 pm – 5:00 pm

12. Respiratory Protection for Biosafety Professionals

This course will provide an overview of respiratory protection personal protection equipment (PPE), including selection considerations for biological and chemical hazards. A deeper dive into key hazards relevant to biosafety professionals and their respiratory protection considerations will follow. While mostly based on U.S. OSHA Respiratory Protection Program requirements, much of theinformation presented will be applicable internationally.

Objectives:

  • Describe the basic process for hazard and exposure assessment necessary for selecting appropriate respiratory protection equipment
  • Identify the types and styles of respiratory protection equipment, in addition to U.S. OSHA requirements for their use
  • Summarize the process of respirator selection and product implementation in their workplace for key hazards

Suggested Background: None
Target Audience: All Biosafety Professionals, All Safety Professionals

Audience Level: Intermediate

COURSE FACULTY

Kathryn Thompson, MPH, MS, CIH, MT(ASCP)Kathryn Thompson, MPH, MS, CIH, MT(ASCP)
Technical Training and Education Specialist
3M
Annandale, MN

Kathryn Thompson has over 30 years of industrial hygiene experience in a variety of industrial andhealthcare applications, including infection control and technical support for disinfectant products. Kathy has been with 3M for the past 28 years and currently supports the selection and use of personal protective equipment with a focus on customers in the pharmaceutical andchemical industries. Kathy is a Certified Industrial Hygienist (CIH) and Medical Technologist MT(ASCP) with a Master of Public Health and MS in Chemistry.

CONTACT HOURS

This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.

Saturday, November 2, 2024, 1:00 PM – 5:00 PM

13. Field Research Safety for Biosafety Professionals

Biosafety professionals are often tasked with reviewing field research protocols, but many biosafety professionals have never received training in field research safety. In this course, attendees will review hazards inherent to fieldwork, lessons learned from past incidents, and assess risk for a variety of field projects. The attendees will discuss safe work practices in the field and exposure control approaches for zoonotic, vector-borne, soil-borne, and water-borne diseases. The course will also assist attendees to identify potential gaps in institutional and regulatory oversight and steps to improve a culture of safety and preparedness in the field.

Objectives:

  • Review common environmental hazards; zoonotic, vector-borne, soil-borne, and water-borne diseases relevant to outdoor or remote fieldwork
  • Evaluate risk tolerance as it relates to protocol and research review
  • Assess risk for a variety of field projects including wildlife research, community health studies, excavating soil, plant surveys, etc.
  • Identify reasonable controls and expectations
  • Describe the compliance drivers, model field safety programs, written field safety plan templates; as well as best practices, technical references and potential actions to improve culture of safety and preparedness in the field

Suggested Background: None
Target Audience: All Biosafety Professionals

Audience Level: Intermediate

COURSE FACULTY

Sara Souza, MPH, CIH, REHS
Univeristy of California—Berkeley EH&S
Berkeley, CA

CONTACT HOURS

This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.

Sunday, November 3, 2024, 8:00 AM – 5:00 PM

14. Medical Emergencies in the Laboratory – Are you prepared?

Biological Sciences form the foundation of medical research and healthcare including: biochemistry, molecular, cellular, developmental biology, microbiology, plant biology/pathology and public health. Biosafety professionals regularly train staff to handle spills, exposure to chemicals, weather related events, power outages, and biosecurity, but what about medical emergencies? Your organization may have emergency response procedures, but are the individuals in the lab, field, or even visitors prepared to handle first aid in situations involving biologicals? Personnel should be able to recognize and react to medical emergencies they may encounter at your institution involving biologicals. Early recognition of potential medical emergencies can reduce long-term or deadly consequences and legal challenges. Medical emergencies may involve only one individual or it can be a large-scale emergency. Prepare your personnel to respond appropriately in order to avoid worsening the situation. Discover ways to improve communication and cooperation with internal emergency response teams and local emergency responders (911 operators, fire, EMS, law enforcement) when biologicals are involved. Consider the impact when First Responders arrive on scene and see a BSL-2 or BSL-3 sign. If an ambulance is required, is the patient ready to transport? Although you cannot predict every emergency, preparing your personnel to think through a response by preplanning for an event and the steps to recovery is necessary to simplify an emergency response. This class will offer guidance and assistance in preparing for emergencies.

Objectives:

  • Establish relationships with local emergency response
  • Summarize the right response in a medical emergency
  • Communicate the decontamination procedures to employees and emergency responders

Suggested Background: Basic first aid
Target Audience: All Safety Professionals, New Biosafety Professionals, Laboratory Workers

Audience Level: Basic

COURSE FACULTY

Deborah Howard, MPH, CBSP(ABSA)Deborah Howard, MPH, CBSP(ABSA)
Global Environment, Health, and Safety Biological Materials Manager
BASF
Durham, NC

Deborah Howard is the Expert, Global Environment, Health & Safety Biological Materials Manager for BASF where she has oversight of greenhouses, laboratories, inoculant, & fermentation sites. She has been the Biosafety Manager at BASF since May 2014. Deborah has extensive experience with IBC’s, IACUC, Select Agent regulations, exporting, greenhouse, arthropods, genetically modified plants, & animals. She has over 30 years of experience in health and safety & knowledge of regulations including NIH, OSHA, EPA, APHIS, & USDA. Previously, she was the Biosafety Manager at UNC Chapel Hill where she was the IBC Administrator for 6 years.

Anita Harrell, BS, BASF, Durham, NC

Anita Harrell, BS
North America Biosafety Manager
BASF
Durham, NC

Anita Harrell has 10 years of experience in the fields of Occupational Safety, Biological Safety and Laboratory Safety. She has worked at BASF for 35 years and is currently the North America Biosafety Manager. Prior to joining BASF, Anita worked at North Carolina State University in Raleigh, NC. She received a degree in Botany from NCSU in 1983. Anita currently oversees the North American Biological Safety Programs. She works with site biosafety representatives to oversee these areas. She participates and several global biosafety teams at BASF.

CONTACT HOURS

This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.

Sunday, November 3, 2024, 8:00 AM – 5:00 PM

15. Pharmaceutical Biosafety Officer Training

The course is intended for Pharma Biosafety Officers (BSOs), BSOs with interest in the biopharmaceutical industry, and can be a complimentary course to Principles and Practices of Biosafety® (PPB) offered by ABSA International. The instructors will review the Biosafety Regulatory Frameworks including key regulations in the U.S. and non-US regulations and key differences between regions. This includes an Introduction to the Biorisk Management Framework and the new ISO Standard. Key topics on Applied Biosafety, including examples of new technologies in industry (e.g., CRISPR, viral vector gene therapy, others), will be discussed as well as a review of the hazard classification of human cell lines, animal blood and tissue samples, a discussion on examples of LAIs (e.g., N. meningitis, rabies), improper inactivation scenarios, and environmental release of biological agents (including a biological agent release scenario—how to handle). Good Manufacturing Practices (GMP) will be discussed including what it is, why it is important, and how to harmonize GMP and biosafety requirements. This interactive course will feature a variety of group exercises where attendees will review engineering design requirements, P&IDs, identify issues, propose recommendations for what is acceptable vs. not, HVAC design, placement and type of equipment, room pressurization, workflow, decontamination (e.g., autoclave, HEPA, kill tanks), process equipment containment. A risk assessment course will be featured as part of the group exercises where attendees will discuss how to complete a risk assessment with certain perameters, then each groups risk assessment will run through an approval process (e.g., IBC) with other groups acting as the IBC and collectively review each other’s risk assessment. The course will conclude with roundtable discussions including the group scenarious, discussions, and further Q&A.

Objectives:

  • Identify the global biorisk management regulatory frameworks as applicable to pharmaceutical companies
  • Restate how to harmonize GMP and biosafety, and how to integrate biosafety principles into engineering design projects (including lab and large-scale)
  • Summarize how to conduct a biorisk assessment and expectations for biosafety committee approval

Suggested Background: Fundamentals of Biosafety, Micro/Molecular Biology 101, Principles and Practices of Biosafety® (PPB), Risk Assessment
Target Audience: All Biosafety Professionals

Audience Level: Intermediate

COURSE FACULTY

Rebecca McGirr, MSc, RBSO(CABS-ACSB), RBP(ABSA)Rebecca McGirr, MSc, RBSO(CABS-ACSB), RBP(ABSA)
Deputy Director, Biosafety and Industrial Hygiene
Sanofi
Toronto, Ontario, Canada

Becky McGirr is currently the Biosafety and Industrial Hygiene Lead for Sanofi’s Toronto site. She holds a Bachelor’s Degree in Biology and a Master’s Degree in Neuroscience from the University of Western Ontario and has a certificate in Occupational Health and Safety. For over 8 years, Becky has worked as a biosafety professional in various settings, in both Canada and the US, including in academic and hospital-based research institutes, and in the biopharmaceutical sector. In her current role, she leads the biosafety and industrial hygiene programs at Sanofi’s Toronto campus and is the site’s biological safety officer. Becky is a member of ABSA’s Distance Learning Committee and Technical and Regulatory Review Committee. She is also a member of the Public Health Agency of Canada’s Advisory Committee on Human Pathogens and Toxins (AC-HPT). Prior to her biosafety career, Becky spent more than 10 years as a Laboratory Manager for basic research laboratories in a hospital-based research institute, specializing in molecular, cell and microbiological techniques.

Leo Njongmeta, MBA, PhD, CSP, RBP(ABSA), CBSP(ABSA)Leo Njongmeta, MBA, PhD, CSP, RBP(ABSA), CBSP(ABSA)
Associate EHS Director | Global Biosafety Officer
AbbVie Inc.
North Chicago, IL

Leo Njongmeta is an Associate EHS Director and Global Biosafety Officer at Abbvie where he leads the Global R&D EHS Center of Excellence comprised of Biosafety, Vivarium Safety, Radiation Safety, Environmental Compliance and Dangerous Goods Shipping programs. His Team is responsible for providing strategic support to drive a Culture of Safety and Environmental Compliance in biomedical research, drug discovery, preclinical safety, and biologics manufacturing. Prior to a career in safety, Leo was a research scientist conducting biomedical research in the fields of immunology, animal models of infectious diseases and vaccine development. Leo possesses a B.Sc in Microbiology, an M.Sc in Molecular Biology, a Ph.D in Veterinary Science (Parasite Immunology) and an MBA in Leadership and Operations Management. Leo is currently an adjunct Assistant Clinical Professor in Environmental and Occupational Health Sciences at the University of Illinois at Chicago (UIC) School of Public Health. Leo holds board certifications in Safety (CBSP(ABSA), CSP), has been an active member of ABSA International serving in various committees which include current elected member of the ABSA Nominating Committee and leadership roles in the ABSA Pharma Biosafety Group.

Elise Franklin, MS, MBA, CSP, CIH, RBP(ABSA)Elise Franklin, MS, MBA, CSP, CIH, RBP(ABSA)
Corporate Biosafety Officer
Bristol Myers Squibb
Princeton, NJ

Elise is the Corporate Biosafety Officer for Bristol Myers Squibb (BMS) and has been with BMS for 13 years. Elise is a CIH, CSP and RBP and has 30+ years in the EHS field with experience in biopharma, biotechnology, academics, heavy industry, high technology and consulting. Her focus areas are Industrial Hygiene, Biosafety, and Ergonomics. She received her B.S. from Colorado State University, her M.S. from UMass-Lowell and her MBA from Babson.

Arif Peshimam, MSOH, MPH, MD, RBP(ABSA)Arif Peshimam, MSOH, MPH, MD, RBP(ABSA)
Global Head of Biosafety
Sanofi
Framingham, MA

Arif Peshimam is the Global Head of Biosafety for Sanofi, a Multinational Pharmaceutical Company. He is responsible for overall biosafety program management for manufacturing and R&D sites within the company. Prior to joining Sanofi, Arif was Corporate BSO for Southern Research, served as a Health Specialist/Industrial Hygienist in Health Safety & Environment at King Abdullah University of Science & Technology in Saudi Arabia, and was the Biosafety Officer and EHS Specialist in the Department of Environmental Health & Safety at the University of California—Riverside (UC Riverside). While at Case Western Reserve University, he implemented the Biological Safety and the Industrial Hygiene Programs from 2003 to 2008.

Arif is a Registered Biosafety Professional (RBP) with ABSA International (American Biological Safety Association) and is trained in OSHA 24-hour HAZWOPER and the National Incident Management System. He holds an MD degree from Grant Medical College in Bombay, India. He received a Master of Public Health in Environmental & Occupational Health through the Northwest Ohio Consortium for Public Health which includes Bowling Green State University and the University of Toledo. He also received a Master of Science in Occupational Health, with a major in Industrial Hygiene from the University of Toledo. He earned a master’s degree in Epidemiology and Biostatistics from Case Western Reserve University.

CONTACT HOURS

This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.

Sunday, November 3, 2024, 8:00 AM – 5:00 PM

16. Commissioning and Recommissioning for BSL-3 Containment Laboratory

By understanding the commissioning and recommissioning processes, it can assist the biosafety professional in start-up or maintaining their laboratory operations to perform the program. Laboratory commissioning, identified in containment guidance documents, is a quality assurance process for the effective functioning of biocontainment laboratories. The biosafety officer and other decision makers benefit by having a basic understanding of the commissioning and recommissioning processes and resulting documentation. This course will review the phases of the new facility commissioning process and similar process for recommissioning. This knowledge base allows the biosafety professional to recognize how commissioning assists in providing and documenting a properly operating facility. A review of the secondary containment features of the BSL-3 laboratory will be disucssed and note specific issues typically observed. There will be a focus on two issues, the reversal of directional airflow and sealing of surfaces and penetrations. Participants will consider methods to identify the issues and present some specific mitigations of these issues; can actively participate in the commissioning/recommissioning processes and understand the methodology, the tools, results, and their interpretation; will know their facility operates correctly, its limitations, and the risk when it does not. This knowledge allows the biosafety professional to check or back check the containment spaces’ performance and use this knowledge to perform daily inspections for maintenance or replacement and control risk to the lowest level. The biosafety professional can identify required features in a new laboratory or review an existing lab with a better understanding of typical issues to assure safe reliable operations.

Objectives:

  • Develop an understanding of the overall commissioning and recommissioning processes for containment labs
  • Articulate the engineering controls required and effectively participate in the processes
  • Identify typical issues observed during commissioning/recommissioning of the laboratory secondary containment barriers and the options for practical solutions to those issues
  • Demonstrate a knowledge base and provide documentation to better perform daily inspections to reduce risk for safe and reliable laboratory operations

Suggested Background: None
Target Audience: All Safety Professionals, Laboratory Workers, Operations and Maintenance Personnel

Audience Level: Intermediate

COURSE FACULTY

Joby Evans, PE, CAC, CBCPJoby Evans, PE, CSCP, CACU
Commissioning Engineer/Technical Lead
Georgia Engineering LLC
Atlanta, GA

Joby Evans has over 35 years in facilities commissioning, support, design, engineering, energy management, and processes for consulting engineering firms, performance contracting group, natural gas distributor, and an international architect/developer. Mr. Evans is proficient in commissioning and in recommissioning high-containment facilities, analyzing the interaction between designs and energy consumption in commercial and industrial facilities and has extensive experience in building commissioning and system design and coordination. He has performed commissioning for BSL-4, BSL-3Ag, BSL-3 laboratories using BMBL, NIH, WHO, ANSI biosafety guidelines. His work has been in the United States and in international locations. Mr. Evans has performed re-commissioning and retro-commissioning on many non-containment facilities including headquarters facilities, hangers, office buildings, etc. He is a Registered Professional Engineer, Licensed Mechanical Contractor, Certified Building Commissioning Professional, Certified Energy Manager, Certified Green Building Engineer, and Guiding Principles Compliance Professional.

CONTACT HOURS

This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.

Sunday, November 3, 2024, 8:00 AM – 5:00 PM

17. Strategies for Designing and Implementing a Culture of Safety

As biosafety professionals, we all desire to foster a culture of safety and responsible conduct at our institutions. We often have a clear vision of how this culture should look and feel, but how do you move from the current organizational culture to the one you desire? This course will define organizational culture; understand how culture forms; and identify artifacts, espoused values, and shared beliefs that can be used to describe an organization’s culture. Attendees will use these definitions to identify attributes of their own organization’s culture that support or block a culture of safety and responsibility. Unfortunately, most change efforts in organizations fail. Changing existing culture is difficult and can take many years. However, several change management models can be employed to develop a roadmap for effecting change. Participants in this course will learn about the Lewin and Kotter change management models and their application. Participants will apply these models to case studies of organizational change to understand how they can be leveraged at their own organizations.

Objectives:

  • Describe what organizational culture is, how to identify and define it, and how it forms
  • Identify attributes of an organization’s culture that block or enable safety programs
  • Apply change management models such as Lewin and Kotter models to effect organizational change

Suggested Background: None
Target Audience: All Safety Professionals, Experienced Biosafety Professionals

Audience Level: Intermediate

COURSE FACULTY

Meghan Seltzer, PhD, RBP(ABSA), The MITRE Corporation, McLean, VA
Meghan Seltzer is a Lead Technical Assessor with The MITRE Corporation. She earned a bachelor’s degree in Biochemistry and Molecular Biology from the Pennsylvania State University, a doctorate in Cellular and Molecular Medicine from Johns Hopkins University School of Medicine, and a master’s degree in Management, Strategy, and Leadership from Michigan State University. Meghan is a Registered Biosafety Professional and began her biosafety career as a fellow in the National Biosafety and Biocontainment Training Program. After completing her fellowship, she worked at HHMI’s Janelia Research Campus as a manager in the Safety, Health, and Security department. During her tenure at HHMI, she was responsible for biosafety and occupational health programs as well as various research compliance efforts including IACUC, CLIA, dangerous goods shipping, import/export compliance, IRB, and IBC. Meghan is active in ABSA and ChABSA where she has served on numerous committees and council for both organizations.

CONTACT HOURS

This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.

Sunday, November 3, 2024, 8:00 AM – 5:00 PM

18. ISO 35001 Implementation Course

In 2019, ISO published a new biorisk management standard that many biomedical research laboratories all over the world are adopting. This course will provide presentations, facilitated discussions and tools to introduce concepts related to biosecurity and biosafety (biorisk) management systems. Participants will learn in-depth both the theory of biorisk management (BRM) systems and how to use the new laboratory biorisk management framework ISO 35001 as a planning tool to map their existing management system to the new standard and identify and prioritize opportunities to improve their existing system using the new ISO standard. Using the ISO 35001 as a planning and mapping tool will enable institutions to effectively identify, assess, control, and monitor the laboratory biosafety and biosecurity risks associated with hazardous biological materials using the concept of continual improvement through the PDCA (Plan-Do-Check-Act) principle.

Objectives:

  • Identify the key elements of a BRM system based on the review sections of the ISO 35001 BRM system standard
  • Map their existing BRM systems to the ISO 35001 and identify both strengths and opportunities to improve existing system
  • Prioritize elements or areas that need improvement
  • Select an area for improvement and identify a simple, short term, project idea to help strengthen one element within their existing system

Suggested Background: None
Target Audience: Experienced Biosafety Professionals, All Safety Professionals

Audience Level: Advanced

COURSE FACULTY

Eric Cook, MPH, Sandia National Laboratories, Albuquerque, NM
Eric Cook, MPH
Senior Member – Technical Staff
Sandia National Laboratories
Albuquerque, NM

Eric Cook is a Senior Member of the Technical Staff in the International Biological and Chemical Threat Reduction Program at Sandia National Laboratories where his work focuses on promoting global laboratory biorisk management. He serves as one of the program’s lead trainers. Eric served as the Biosafety Officer for Dartmouth College in Hanover, NH for five years where he managed the Biosafety Program and Institutional Biosafety Committee. Prior to working at Dartmouth, Eric was an Assistant Biosafety Officer at the Massachusetts Institute of Technology for six years. While at MIT, Eric completed his Master’s Degree in Public Health at Boston University with a focus on Environmental Health. Eric has a B.S.in Molecular Biology from Brigham Young University where he worked in a recombinant DNA lab for two years assisting with work in phylogenetics. He is certified by the National Registry of Certified Microbiologists as a Specialist Microbiologist in Biological Safety Microbiology and previously by ABSA International as a Certified Biological Safety Professional. Eric has particular expertise in dangerous goods and infectious substance shipping. He worked for three years at Saf-T-Pak, Inc. developing training programs and packaging for shipping infectious substances.

Rawan KhasawnehRawan Khasawneh
Team Leader
Biorisk Management Training Division
Princess Haya Biotechnology Center
Jordan University of Science and Technology
Irbid, Jordan

Rawan Khasawneh is the team leader of biorisk management training division (BRMTD) at Princess Haya Biotechnology Center / Jordan University of Science and Technology. Her work focuses on developing and implementing strategic and sustainable biorisk management training on a regional basis. She is responsible for the coordination of biorisk management training events for professionals of different sectors from Jordan and the MENA region, and teaching them using interactive learning techniques. Ms. Khasawneh has implemented several projects with national and international organizations to support the building up and improvements of biorisk management system in the MENA region. In addition, she has experience in the biotechnology field in diagnostic and research labs where she used molecular techniques such as microarray, DNA sequencing, real-time PCR, and conventional PCR to study the genetics of cancer, gene expression, and detection of viral agents. She obtained her master of science in applied medical sciences from Jordan University of Science and Technology, and professional certification in biorisk management and biosecurity from the International Federation of Biosafety Associations (IFBA).

Kalpana Rengarajan, PhD, MPH, RBP(ABSA), Emory University, Atlanta, GAKalpana Rengarajan, PhD, MPH, JM, RBP(ABSA)
Director of Research Safety | Senior Biosafety Officer
Emory University
Atlanta, GA

Kalpana Rengarajan is the Director of Research Safety at the Environmental Health and Safety Office (EHSO) and is the Senior Biosafety Officer for Emory University. EHSO has University-wide responsibility for all aspects of Environmental Health and Safety support, including Biosafety and EHS compliance support to Emory Healthcare. This includes biosafety support to the Emory Serious Communicable Diseases Unit (SCDU), which cared for 4 Ebola patients in 2014. The SCDU continues to be a major leader in the U.S. National Ebola Training Center. Her background includes a PhD in Immunology and she has worked as a Visiting Associate at the National Eye Institute, NIH. Prior to joining EHSO she worked as a Research Associate at the Emory Vaccine Center. Kalpana has a passion for Global Biorisk Management Public Health Preparedness and provides guidance internationally. She has a Masters of Public Health from Rollins School of Public Health (Emory University) and a Juris Masters of Law (Emory University). She is a Registered Biosafety Professional. Dr. Rengarajan serves on committees for the ABSA International (American Biological Safety Association) and the Campus Safety Health and Environmental Association (CSHEMA), to create professional development courses, and is a member of the technical writing team for ISO/TC 212/Working Group 5 (ISO Laboratory Biorisk management standard), and was a technical writer for the CEN Workshop Agreements relating to Biorisk Management Systems: CWA 15793:2011 and 16393: 2012. Dr. Rengarajan regularly teaches/facilitates and presents at ABSA and CSHEMA. She has also been teaching for the Laboratory Leadership Service (LLS) program at CDC.

CONTACT HOURS

This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.

Sunday, November 3, 2024, 8:00 AM – 12:00 PM

19. The Big, Bright Beautiful World of BSL-2

In the world of biosafety, balancing risk management with potential uncertainties can be tricky. We have all heard the adage that in biosafety, “it depends”, and nowhere is this a more accurate statement than in a biosafety level 2 (BSL-2) laboratory. Unlike the clear-cut requirements of other containment levels, BSL-2 boasts a spectrum of flexibility that can be both empowering and confusing. Housing agents from Risk Group categories 1 through 3, BSL-2 laboratories can resemble the “wild west” of biosafety. While this adaptability allows tailored safety protocols, it also provides a breeding ground for uncertainty and potential for error. When does a BSL-1 space become a BSL-2 lab or BSL-2 become a BSL-3? Where do recommendations end and requirements begins? When can an RG-3 agent be handled in a BSL-2 laboratory, and why? From understanding airflow requirements and choosing the right biosafety cabinet (if you need it) to choosing crafting functional safety protocol and assessing the highly controversial BSL-2+, this course is intended for the biosafety novice to delve deeper into the ever fluid BSL-2 space and gain confidence navigating the waters where “it depends”.

Objectives:

  • Distinguish between recommendations and requirements for BSL-2 laboratories
  • Identify when RG-3 agents are handled under BSL-2 containment and when should RG-1 agents be moved to BSL-2
  • Restate how to adjust the 3 risk mitigation controls to get to meet specific biosafety needs and what is “BSL-2+”

Suggested Background: None
Target Audience New Biosafety Professionals, Laboratory Workers, Clinicians, EHS, Other safety professionals who work with biological materials

Audience Level: Basic

COURSE FACULTY

Heidi Page, MS, RBP(ABSA), SABAI Global—Shield Consulting, Chesterfield, MOHeidi Page, MS, RBP(ABSA)
SABAI Global—Shield Consulting
Chesterfield, MO

Heidi has extensive experience in, and passion for, the ‘grey zone’, intertwining regulation, safety and human behavior to find the best overall solutions to the safety and compliance challenges we face when doing research. Heidi has 15+ years of experience in the field of biosafety and has over 7 years of experience serving as the Biological Safety Officer and Assistant Director of Environmental Health and Safety at Case Western Reserve University. She earned a BS in Organismal Biology from the University of Kansas, a MS in Cell and Molecular biology from University of Missouri—Kansas City and is a Registered Biosafety Professional with ABSA International. In her role as the Director of Sabai’s Shield Consulting group, Heidi has the opportunity to work with varied clients from academic institutions, CROs, startup biotechs, large pharma, and healthcare institutions. Outside of work Heidi is often found trying her hand at something new, be it gardening, cooking, raising chickens or keeping bees. She feels passionately that there is always something new to learn.

CONTACT HOURS

This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.

Sunday, November 3, 2024, 8:00 AM – 12:00 PM

20. Implementing Field Biosafety Levels: Standardizing Safety Across Disciplines

The challenge of standardizing biosafety in field settings, especially in studies involving zoonotic disease transmission, has historically been complicated by inconsistent guidance from various institutional biosafety committees, Institutional Animal Care and Use Committees (IACUCs), and governmental agencies. This inconsistency often stems from differing levels of field experience and expertise among these groups. This course will address this gap by introducing a set of innovative Field Biosafety Levels (FBSLs) aimed at establishing uniform safety guidelines applicable to all researchers, regardless of their scientific discipline or the nature of their field work. This course will guide attendees through the critical processes of identifying primary hazards, conducting thorough risk assessments, and applying the novel FBSL framework effectively in their projects. By following a structured hierarchy of hazard controls, the FBSL framework provides the first comprehensive, risk-based guidelines designed to enhance health preparedness, enforce rigorous hygiene practices, ensure effective decontamination procedures, and manage waste efficiently. Additionally, the course will explore a tiered system of personal protective equipment (PPE) selection, tailored to varying levels of exposure and risk. Attendees will leave with a deeper understanding of how to integrate these standards into their fieldwork, resulting in improved safety outcomes and reduced risk of pathogen transmission. This course is crucial for researchers seeking to elevate the safety protocols of their field studies, providing them with the tools and knowledge to implement best practices consistently and effectively.

Objectives:

  • Identify and apply FBSLs to effectively apply standards to various types of field research
  • Apply techniques to conduct thorough risk assessments tailored to field settings
  • Implement enhanced health and safety protocols

Suggested Background: Fundamentals of Biosafety, Principles and Practices of Biosafety® (PPB), Risk Assessment, Virology/Viral Vectors
Target Audience: All Safety Professionals, Scientists conducting activities in the field

Audience Level: Basic

COURSE FACULTY

Marc Valitutto, VMD (Veterinarian)
Field Biosafety Solutions
New York, NY

Dr. Marc Valitutto is a senior field veterinarian at EcoHealth Alliance, where he focuses on pandemic preparedness throughout the world. He is involved in collaborative research investigating wildlife as a zoonotic disease reservoir, as well as identifying ways of protecting endangered species in their natural habitats. His primary focus is on animal welfare and occupational safety through the advancement of animal biosurveillance methods and developing practical biosafety solutions for field participants, respectively. He previously served as global lead for the USAID Emerging Pandemic Threats PREDICT project in Myanmar, where he and his colleagues detected novel coronaviruses in endemic bat populations. He received his Doctorate of Veterinary Medicine from the University of Pennsylvania and completed a four-year residency in zoological medicine and surgery at the Wildlife Conservation Society and Cornell University. Prior to joining EcoHealth Alliance, he served in various roles focused on animal health and conservation. His work has been featured on several media outlets, including CBS’s 60 Minutes and NBC’s Today Show.

CONTACT HOURS

This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.

Sunday, November 3, 2024, 1:00 PM – 5:00 PM

21. Lessons Learned to Improve Biosafety

Preventing laboratory-acquired infections (LAIs) is a challenge for laboratory managers and biosafety professionals, especially when dealing with an emerging pathogen. It is extremely important to quickly determine if there has been an exposure, how many may have been exposed, what steps need to happen next, including any prophylaxis, root cause analysis, gaps in the biosafety plan, and additional mitigation measures that need to be implemented. This interactive course will examine published papers from the ABSA LAI Database on laboratory acquired infections and exposures to determine what we can learn to prevent future exposures. Attendees will thoroughly examine the literature on the history of lab-acquired infections, review specific published articles, utilize the Association of Public Health Laboratories (APHL) ‘Laboratory Exposure Assessment and Symptom Monitoring Guide’ (exposure assessment tool) to assess exposures, analyze data to identify root causes of exposures, discuss identified gaps, and establish additional steps required to mitigate risks. Afterwards, attendees will divide into groups and receive new scenarios from the database. Using the APHL exposure assessment tool, they will apply the process demonstrated earlier—from determining exposure to conducting root cause analysis, identifying gaps, and proposing mitigation steps to prevent recurrence. Attendees will then learn to utilize published data on lab-acquired infections and these tools to safely handle emerging pathogens.

Objectives:

  • Describe how the ABSA LAI database can be used for biosafety training and determining how to safely work with emerging pathogens
  • Utilize the APHL exposure assessment tool to assess real-life laboratory incidents for potential exposures and to help guide prophylaxis if indicated
  • Analyze actual laboratory incidents to determine the root cause and what steps are necessary to mitigate future incidents

Suggested Background: Fundamentals of Biosafety, Risk Assessment
Target Audience: All Safety Professionals, Laboratory Workers

Audience Level: Intermediate

COURSE FACULTY

Michael Pentella, PhD, SM(ASCP), CIC, D(ABMM)
State Hygienic Laboratory at the University of Iowa
Coralville, IA

Dr. Pentella is a Clinical Professor at the University of Iowa, College of Public Health and Director of the Iowa State Hygienic Laboratory. His experience spans over forty years in clinical microbiology and public health laboratories. He is certified as an American Board of Medical Microbiology Diplomate, a specialist in microbiology through the American Society for Clinical Pathology and certified in infection control through the Association of Professionals in Infection Control. Dr. Pentella is a member of the APHL Biosafety and Biosecurity Committee, Antibiotic Resistance Lab Workgroup, the Infectious Disease Committee, and the Respiratory Viruses Subcommittee. He has made several contributions that have improved the practice of clinical microbiology and biosafety. He has written over 50 articles and twenty book chapters.

Erin Bowles, BS, MT(ASCP)Erin Bowles, BS, MT(ASCP)
Laboratory Network Coordinator
Wisconsin State Laboratory of Hygiene
Madison, WI

Erin Bowles is the Laboratory Network Coordinator for the Wisconsin State Laboratory of Hygiene’s Communicable Disease Division, where she provides outreach and education to more than 125 laboratories in Wisconsin in order to ensure a coordinated statewide response to any biological threats of public health importance. Her background in clinical microbiology and expertise in biosafety serve her well as a member of APHL’s Workforce Development Committee, the Sentinel Laboratory Outreach and Partnership Subcommittee, and the Sentinel Laboratory Training Special Interest Group. Some of the committee projects that she has contributed to are revisions to the ASM Sentinel Level Clinical Laboratory Guidelines and the development of risk assessment training and biosafety tools such as the “Clinical Laboratory Preparedness and Response Guide”.

Shoolah Escott, MS(MLS), MT(ASCP)
Consultant
Lexington, MA

Shoolah Escott is currently an independent, Biosafety, Biosecurity, and Bioterrorism Preparedness Trainer and a COVID-19 Contact Tracer with Partners In Health. She was the Biosafety Manager and ARO at the MA State Public Health Laboratory for over 2 years where she provided biosafety training and support to over 50 clinical laboratories and to internal public health laboratory staff. She worked for APHL/CDC National Laboratory Training Network, CDC Laboratory Training Branch for over 17 years developing, implementing, delivering, and presenting national training programs in biosafety, biosecurity and bioterrorism preparedness. She has a strong background in clinical microbiology and was the safety officer for the Memorial Hospital clinical laboratory. Currently, she serves on several ABSA and APHL committees. Here are a few key biosafety accomplishments: What Constitutes an Effective Biosafety Plan at the World Microbe Forum; Biosafety and Biosecurity: Minimizing the Risks in the Laboratory and Clinical Laboratory Biosafety Risk Assessment seminars presented nationally multiple times; and the lead on the initial development and revision of the Clinical Laboratory Preparedness and Response Guide.

Michael Perry, MS EdMichael Perry, MS, MS Ed
Associate Director of the Biodefense Laboratory | Alternate Responsible Official
New York State Department of Health—Wadsworth Center
Albany, NY

Michael Perry is the associate director of the Biodefense Laboratory at the New York State Department of Health – Wadsworth Center. As the ARO, APHL Biosafety and Biosecurity committee member and a member of the Wadsworth Center institutional biosafety committee, Michael has extensive training and expertise in biosafety. As part of the Global Health Security Agenda, Michael was the lead trainer for APHL’s Global Health program, developing and providing trainings in the proper use, operation, and maintenance of biological safety cabinets and biorisk management for international public health laboratorians in Africa. Over the last 10 years, Michael has conducted numerous sentinel laboratory site visit which focused on the evaluation of both laboratory biosafety which a focus on assistance with risk assessments and risk mitigation strategies.

CONTACT HOURS

This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.

Sunday, November 3, 2024, 1:00 PM – 5:00 PM

22. Navigating Regulatory Audits in Biosafety: Strategies for Success

In biosafety, regulatory compliance is paramount to ensure the safe handling of biological materials and maintain the integrity of research and healthcare activities. This course is designed to equip biosafety professionals, laboratory managers, and clinical research personnel with the knowledge and strategies to prepare for and successfully navigate regulatory audits. The course, filled with practical and applicable content, will cover critical regulatory frameworks relevant to biosafety, including those outlined by the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the Occupational Safety and Health Administration (OSHA). Attendees will gain insights into audit preparation techniques, documentation requirements, and best practices for ensuring compliance with regulatory standards. Through interactive discussions, case studies, and mock audit scenarios, attendees will learn how to identify potential audit pitfalls, address non-compliance issues, and implement corrective actions to strengthen their biosafety programs. Whether preparing for routine inspections or facing an unanticipated audit, this course will provide invaluable guidance and practical strategies to navigate regulatory audits confidently and successfully.

Objectives:

  • Develop a comprehensive audit preparation plan incorporating documentation requirements outlined by regulatory agencies such as the CDC, NIH, and OSHA
  • Demonstrate proficiency in identifying potential audit pitfalls and addressing non-compliance issues within a biosafety program
  • Interpret audit findings and implement corrective actions to strengthen a biosafety program and improve regulatory compliance practices

Suggested Background: None
Target Audience: All Safety Professionals, New Biosafety Professionals, Laboratory Worker

Audience Level: Intermediate

COURSE FACULTY
Sarah Ziegler, PhD, RBP(ABSA), CBSP(ABSA), SM(NRCM), Sitero, Coral Gables, FLSarah Ziegler, PhD, RBP(ABSA), CBSP(ABSA), SM(NRCM)
Sitero
Coral Gables, FL

Ryan Barlett, MS, RBP(ABSA), CBSP(ABSA), CPBCA
Sitero
Coral Gables, FL

Joanie Ryan, PhD
Colorado State University
Fort Collins, CO

Frank McAneny, MS, MBA
Sitero
Coral Gables, FL

CONTACT HOURS

This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.